Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 3 studies | 53% ± 17% |
Insufficient scRNA-seq data for expression of CA5A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1784.79 | 226 / 226 | 84% | 18.79 | 342 / 406 |
brain | 98% | 28.31 | 2601 / 2642 | 19% | 0.35 | 137 / 705 |
ovary | 72% | 5.64 | 129 / 180 | 1% | 0.02 | 5 / 430 |
thymus | 52% | 2.94 | 341 / 653 | 19% | 0.42 | 112 / 605 |
lung | 47% | 2.52 | 269 / 578 | 4% | 0.21 | 47 / 1155 |
heart | 45% | 4.77 | 384 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 44% | 4.58 | 412 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 44% | 2.24 | 113 / 258 | 0% | 0.01 | 1 / 230 |
spleen | 43% | 3.16 | 103 / 241 | 0% | 0 | 0 / 0 |
kidney | 29% | 1.64 | 26 / 89 | 2% | 0.06 | 20 / 901 |
pancreas | 28% | 1.27 | 91 / 328 | 0% | 0 | 0 / 178 |
prostate | 27% | 1.29 | 67 / 245 | 0% | 0 | 0 / 502 |
blood vessel | 25% | 1.21 | 337 / 1335 | 0% | 0 | 0 / 0 |
adipose | 24% | 1.28 | 293 / 1204 | 0% | 0 | 0 / 0 |
uterus | 23% | 1.03 | 39 / 170 | 1% | 0.01 | 4 / 459 |
breast | 24% | 1.23 | 108 / 459 | 0% | 0.01 | 2 / 1118 |
skin | 21% | 0.93 | 379 / 1809 | 0% | 0 | 0 / 472 |
intestine | 18% | 0.72 | 176 / 966 | 1% | 0.03 | 4 / 527 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.38 | 5 / 29 |
muscle | 16% | 0.72 | 130 / 803 | 0% | 0 | 0 / 0 |
stomach | 14% | 0.62 | 50 / 359 | 1% | 0.03 | 2 / 286 |
esophagus | 12% | 0.47 | 170 / 1445 | 1% | 0.01 | 1 / 183 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.03 | 5 / 504 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006730 | Biological process | one-carbon metabolic process |
GO_0005737 | Cellular component | cytoplasm |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004089 | Molecular function | carbonate dehydratase activity |
Gene name | CA5A |
Protein name | Carbonic anhydrase 5A, mitochondrial (EC 4.2.1.1) (Carbonate dehydratase VA) (Carbonic anhydrase VA) (CA-VA) Carbonic anhydrase 5A Carbonic anhydrase (EC 4.2.1.1) |
Synonyms | CA5 |
Description | FUNCTION: Mitochondrial carbonic anhydrase that catalyzes the reversible conversion of carbon dioxide to bicarbonate/HCO3 . Mitochondria are impermeable to HCO3, and thus this intramitochondrial carbonic anhydrase is pivotal in providing HCO3 for multiple mitochondrial enzymes that catalyze the formation of essential metabolites of intermediary metabolism in the urea and Krebs cycles . . FUNCTION: Reversible hydration of carbon dioxide. . FUNCTION: Reversible hydration of carbon dioxide. . |
Accessions | ENST00000649158.1 A0A3B3IRX9 P35218 A0A3B3ITA6 ENST00000649794.3 ENST00000648177.1 ENST00000648022.1 A0A3B3ITU9 |